Enhancement of Recombinant Human Endostatin on the Radiosensitivity of Human Pulmonary Adenocarcinoma A549 Cells and Its Mechanism

Table 5

Cell cycle in each group under normoxia and hypoxia (%, 𝑥⁻±S).

Groups	Normoxia			Hypoxia
	G0/G1	S	G2/M	G0/G1	S	G2/M
Control	61.54±0.98	37.81±0.25	5.43±0.38	59.73±0.91	36.23±0.23	5.49±0.39
Radiotherapy	65.74±0.49	27.91±0.89	8.71±0.61	55.12±0.84	39.19±0.74	6.19±0.26
Endostar + radiotherapy	66.55±0.77	27.16±0.93	8.87±0.62^*	69.12±0.54	11.01±0.83	22.41±0.77^∆•

Note: ^*indicates 𝑃=0.028 compared with radiotherapy group under normaxia; ^∆indicates 𝑃=0.000 compared with radiotherapy group under hypoxia; ^•indicates 𝑃=0.003 compared with endostar + radiotherapy group under normoxia.